Literature DB >> 2190829

Prospects for monoclonal antibodies in the diagnosis and treatment of bacterial infections.

J Verhoef1, R Torensma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2190829     DOI： 10.1007/bf01968054

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  13 in total

1.  Monoclonal antibodies: a potentially powerful tool in the diagnosis and treatment of infectious diseases.

Authors:  G Spira; R R Pollock; A Bargellesi; M D Scharff
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

2.  Enhanced hybridoma production by electrofusion in strongly hypo-osmolar solutions.

Authors:  J J Schmitt; U Zimmermann
Journal:  Biochim Biophys Acta       Date:  1989-07-24

3.  Immunochemical and biological reactivity of human anti-lipopolysaccharide IgG obtained by screening of blood donors.

Authors:  A Fomsgaard; G H Zhang; G H Shand; K Bendtzen; L Baek
Journal:  Scand J Immunol       Date:  1989-03       Impact factor: 3.487

4.  Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus.

Authors:  A O Shigeoka; S H Pincus; N S Rote; H R Hill
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

5.  Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus.

Authors:  K S Kim; C A Wass; J H Kang; B F Anthony
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

6.  Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma.

Authors:  R A Miller; A R Oseroff; P T Stratte; R Levy
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

7.  In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.

Authors:  G B Pier; D Thomas; G Small; A Siadak; H Zweerink
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

8.  Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.

Authors:  M F Salles; E Mandine; R Zalisz; M Guenounou; P Smets
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

9.  Antibodies to lipid A: occurrence in humans.

Authors:  I Mattsby-Baltzer; C R Alving
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

Review 10.  Clinical applications of monoclonal antibodies.

Authors:  H Krakauer
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267
View more
  1 in total

1.  Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.

Authors:  H M Kuhn
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.